Prasco Laboratories to Offer Generic Sular
Prasco Laboratories is expanding its supply agreement with Shionogi Inc. to market and distribute the authorized generic version of Sular (Nisoldipine) Extended Release Tablets. They will be available in 8.5 mg, 17 mg, and 34 mg strengths in the United States.
"Prasco's Authorized Generic of Sular will bring the quality and reliable supply of the brand drug while also offering additional choices and savings to consumers and patients," said David Vucurevich R.Ph., president and COO of Prasco, in a press release. "By selecting an Authorized Generic strategy, pharmaceutical companies can obtain a lifecycle management solution that provides patients, pharmacists and physicians with the therapeutically equivalent product and generic savings."
Prasco Laboratories is a privately held pharmaceutical company located in Mason, OH. For more information, visit www.prasco.com.